
With China’s economy recovering from a real estate development crisis and rising COVID-19 cases in 2022, it only sets up growth potential for 2023. One area of interest that exchange-traded fund (ETF) investors may want to consider is the biotech sector.
Read more: Capture the Growth Potential in China’s Biotech Sector With This ETF








